Difference between revisions of "Talk:P16"
Jump to navigation
Jump to search
Line 32: | Line 32: | ||
WHO 2022 ( https://pubmed.ncbi.nlm.nih.gov/36221864/ ): block type positivity = positive | WHO 2022 ( https://pubmed.ncbi.nlm.nih.gov/36221864/ ): block type positivity (not further specified) = positive |
Latest revision as of 16:03, 17 March 2025
p16 non-oropharyngeal sites
ENT surgeons may over interpret p16 staining in non-oropharyngeal sites. This disclaimer may be useful:
Note: p16 staining in non-oropharyngeal sites is nonspecific in a diagnostic context.
More on p16 in oral sites
- p16 in oral sites usually not HPV driven. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836441/
Cutaneous SCC
- p16 positive in ~ 1/3 cases - https://pubmed.ncbi.nlm.nih.gov/28663082/
p16 UCC
https://pubmed.ncbi.nlm.nih.gov/20164052/
p16 +ve H&N SqCC vs Lung Primary
Lung primaries are commonly positive for p16[1]; thus, p16 CANNOT be used to reliably differentiate between p16 positive head and neck cancers and lung cancer. 1. Br J Cancer. 2000 Jan;82(2):374-80. doi: 10.1054/bjoc.1999.0929. https://pubmed.ncbi.nlm.nih.gov/10646891/ https://doi.org/10.1054/bjoc.1999.0929
Penile ca
https://doi.org/10.1158/1055-9965.EPI-18-0322 Meta-analysis showed p16 IHC criteria variable
WHO 2022 ( https://pubmed.ncbi.nlm.nih.gov/36221864/ ): block type positivity (not further specified) = positive